AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2025
Dec 5, 2025
31201_dirs_2025-12-05_25954f8d-42ae-40dd-a719-58b018440c4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2025-12-03
Reporting Person: Weill David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Common Stock | M | 5000 | $14.20 | Acquired | 17134 | Direct |
| 2025-12-03 | Common Stock | S | 5000 | $138.64 | Disposed | 12134 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | Stock Option (Right to Buy) | $14.20 | M | 5000 | Disposed | 2030-06-04 | Common Stock (5000) | Direct |
Footnotes
F1: The option is fully vested.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20